ECTRIMS 2025 ePoster

Introduction: Due to its significant impact on disability, optic neuritis (ON) is most frequently investigated in the context of demyelinating diseases, and especially multiple sclerosis (MS). Objectives/Aims: We aimed to report the incidence of ON worldwide and beyond occurrence in demyelinating diseases. Methods: Literature search was performed in accordance with PRISMA guidelines, and included articles published between January 2010 and March 2025, written in English and indexed in PubMed. To identify relevant studies, the following keywords sequence was used: ((optic neuritis[Title]) AND (incidence[Title/Abstract])). Results: A review of 56 articles on ON incidence identified 10 relevant studies in Europe, Americas and Asia, in both pediatric and adult populations. The highest mean incidence rate of ON is reported for Canada, with 75.9 [95% CI: 72.1–79.1]/100,000 person-years. The U.S. Armed Forces reported 8.1, while Olmsted County, Minnesota, recorded 4.0 [95% CI: 3.2–4.7]; in this study, 9% of ON cases were associated with NMO and MOG antibodies, and 57% with MS. A study from Barcelona reported a rate of 5.36, higher than that in the United Kingdom – 4.5 [95% CI: 4.3–4.6]. In contrast, the lowest rates were recorded in South Korea, ranging between 2.34 [95% CI: 2.20–2.49] and 3.29 [95% CI: 3.28–3.30]. A Danish study reported an incidence of 3.28 [95% CI: 2.44–4.31], with 39% of patients developing MS during the follow-up. In the pediatric population, the lowest incidence was observed in the United Kingdom – 0.77 [95% CI: 0.64–0.90], while Asian countries, such as South Korea and Taiwan, recorded rates of 1.04 [95% CI: 1.01–1.07] and between 1.79 and 2.46, respectively. Conclusion: The incidence of ON widely varies by world regions, age group, and sex. Rates are higher in women than men the highest peak being in, middle-aged adults, and are lower in children. Western countries report higher incidence rates compared to Asian countries. Several factors, including healthcare access, changes in diagnostic criteria, and environmental conditions are hypothesized to explain these differences. Future research should further explore the ON-MS relationship, and, for more recent times, the potential influence of external factors like the COVID-19 pandemics.

Publication Details

Journal
Multiple Sclerosis Journal
Published
2025-09-01
DOI
https://doi.org/10.1177/13524585251358343
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ECTRIMS 2025 ePoster

Multiple Sclerosis Journal
Multiple Sclerosis Research Studies
article

ECTRIMS 2025 ePoster

article en

Abstract

Introduction: Due to its significant impact on disability, optic neuritis (ON) is most frequently investigated in the context of demyelinating diseases, and especially multiple sclerosis (MS). Objectives/Aims: We aimed to report the incidence of ON worldwide and beyond occurrence in demyelinating diseases. Methods: Literature search was performed in accordance with PRISMA guidelines, and included articles published between January 2010 and March 2025, written in English and indexed in PubMed. To identify relevant studies, the following keywords sequence was used: ((optic neuritis[Title]) AND (incidence[Title/Abstract])). Results: A review of 56 articles on ON incidence identified 10 relevant studies in Europe, Americas and Asia, in both pediatric and adult populations. The highest mean incidence rate of ON is reported for Canada, with 75.9 [95% CI: 72.1–79.1]/100,000 person-years. The U.S. Armed Forces reported 8.1, while Olmsted County, Minnesota, recorded 4.0 [95% CI: 3.2–4.7]; in this study, 9% of ON cases were associated with NMO and MOG antibodies, and 57% with MS. A study from Barcelona reported a rate of 5.36, higher than that in the United Kingdom – 4.5 [95% CI: 4.3–4.6]. In contrast, the lowest rates were recorded in South Korea, ranging between 2.34 [95% CI: 2.20–2.49] and 3.29 [95% CI: 3.28–3.30]. A Danish study reported an incidence of 3.28 [95% CI: 2.44–4.31], with 39% of patients developing MS during the follow-up. In the pediatric population, the lowest incidence was observed in the United Kingdom – 0.77 [95% CI: 0.64–0.90], while Asian countries, such as South Korea and Taiwan, recorded rates of 1.04 [95% CI: 1.01–1.07] and between 1.79 and 2.46, respectively. Conclusion: The incidence of ON widely varies by world regions, age group, and sex. Rates are higher in women than men the highest peak being in, middle-aged adults, and are lower in children. Western countries report higher incidence rates compared to Asian countries. Several factors, including healthcare access, changes in diagnostic criteria, and environmental conditions are hypothesized to explain these differences. Future research should further explore the ON-MS relationship, and, for more recent times, the potential influence of external factors like the COVID-19 pandemics.

Multiple Sclerosis JournalVol. 31(3_suppl)
Openalex Percentile: Top 65%
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

ECTRIMS 2025 ePoster · Multiple Sclerosis Journal (2025) | TGRS Research Map | TGRS